What is the current Price Target for the Benitec Biopharma Inc stock?

The average Benitec Biopharma Inc target price is $26.83. This is 106.25% higher than the current stock price. The highest price target is 169.02%, the lowest is 38.36%. 6 Analysts have issued a price target Benitec Biopharma Inc 2026 .

How high will the Benitec Biopharma Inc stock rise?

No reliable answer can be given as to how high the Benitec Biopharma Inc stock will rise. The performance of stocks, including the Benitec Biopharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Benitec Biopharma Inc stock today?

The performance of Benitec Biopharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Benitec Biopharma Inc stock fall?

The decline in Benitec Biopharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Benitec Biopharma Inc Forecast, price target & analysts

$11.48

11.80% today

Nasdaq, Apr 04, 07:18 pm CET

ISIN

US08205P1003

Symbol

BNTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Benitec Biopharma Inc Target price 2025 - Analyst rating & recommendation

Benitec Biopharma Inc Classifications & Recommendation:

Buy

100%

Benitec Biopharma Inc Price Target

Target Price	$26.83
Price	$13.01
Potential	106.25% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Benitec Biopharma Inc 2026 . The average Benitec Biopharma Inc target price is $26.83. This is 106.25% register free of charge higher than the current stock price. The highest price target is $35.00 169.02% register free of charge , the lowest is $18.00 38.36% register free of charge .
	A rating was issued by 6 analysts: 6 Analysts recommend Benitec Biopharma Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Benitec Biopharma Inc stock has an average upside potential 2026 of 106.25% register free of charge . Most analysts recommend the Benitec Biopharma Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Jun '24	2025 Estimates
Earnings Per Share $	-5.51	1.61
	60.98%	129.22%
P/E		8.08

1 Analysts have issued a Benitec Biopharma Inc forecast for earnings per share. The average Benitec Biopharma Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-5.51	60.98%
2025	$1.61 129.22% Unlock
2026	$-3.72 331.06% Unlock
2027	$-3.22 13.44% Unlock
2028	$-2.73 15.22% Unlock
2029	$0.30 110.99% Unlock

Current	-4.38	812.50%
2025	8.08 284.47% Unlock
2026	-3.50 143.32% Unlock
2027	-4.04 15.43% Unlock
2028	-4.77 18.07% Unlock
2029	43.37 1,009.22% Unlock

Benitec Biopharma Inc...

Current Benitec Biopharma Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 24 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 18 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 21 2025
Baird	Locked ➜ Locked	Locked	Dec 13 2024
Guggenheim	Locked ➜ Locked	Locked	Dec 03 2024
Oppenheimer	Locked ➜ Locked	Locked	Oct 16 2024
JMP Securities	Locked ➜ Locked	Locked	Oct 14 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 24 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 18 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 21 2025
Locked Baird: Locked ➜ Locked	Dec 13 2024
Locked Guggenheim: Locked ➜ Locked	Dec 03 2024
Locked Oppenheimer: Locked ➜ Locked	Oct 16 2024
Locked JMP Securities: Locked ➜ Locked	Oct 14 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now